Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas-Reference-Cited by-同舟云学术

Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Published:2019-02-07 Issue:1 Volume:19 Page:
ISSN:1472-6823
Container-title:BMC Endocrine Disorders
language:en
Short-container-title:BMC Endocr Disord

Author:

Roberto Giuseppe^ORCID,Barone-Adesi Francesco,Giorgianni Francesco,Pizzimenti Valeria,Ferrajolo Carmen,Tari Michele,Bartolini Claudia,Da Cas Roberto,Maggini Marina,Spila-Alegiani Stefania,Francesconi Paolo,Trifirò Gianluca,Poluzzi Elisabetta,Baccetti Fabio,Gini Rosa

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1186/s12902-019-0334-y.pdf

Reference29 articles.

1. Drucker DJ, Nauck MA. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet. 2006;368:1696–705.

2. White J. Efficacy and safety of incretin based therapies: clinical trial data. J Am Pharm Assoc (2003). 2009;49(Suppl 1):S30–40.

3. Standards of medical care in diabetes--2015. Diabetes Care 2015; 38 Suppl 1.

4. Brunton S. GLP-1 receptor agonists vs. DPP-4 inhibitors for type 2 diabetes: is one approach more successful or preferable than the other? Int J Clin Pract. 2014;68:557–67.

5. Montilla S, Marchesini G, Sammarco A, Trotta MP, Siviero PD, Tomino C, et al. Drug utilization, safety, and effectiveness of exenatide, sitagliptin, and vildagliptin for type 2 diabetes in the real world: data from the Italian AIFA anti-diabetics monitoring registry. Nutr Metab Cardiovasc Dis. 2014;24:1346–53.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patterns of anti‐CGRP mAbs use and variation of triptan consumption following treatment initiation: A descriptive drug utilization study in the Tuscany region, Italy;Headache: The Journal of Head and Face Pain;2023-10-13

2. Utilization patterns, cardiovascular risk, and concomitant serotoninergic medications among triptan users between 2008 and 2018: A gender analysis in one Italian region, Tuscany;Headache: The Journal of Head and Face Pain;2023-01-27

3. Changing Patterns of Antihyperglycaemic Treatment among Patients with Type 2 Diabetes in Hungary between 2015 and 2020—Nationwide Data from a Register-Based Analysis;Medicina;2022-10-01

4. Time to Treatment Intensification in Patients Receiving DPP4 Inhibitors Versus Sulfonylureas as the First Add-On to Metformin Monotherapy: A Retrospective Cohort Study;Frontiers in Pharmacology;2022-05-30